A team led by Harvard bioengineer David Mooney has developed an “Implantable Living Materials” platform, which aims to provide synthetically engineered, living cells that can sense injury or disease-associated conditions in their environment and deliver the right amount of a therapeutic molecule directly to where it’s needed to aid recovery.